Quantitative monitoring of neuromuscular blockade is vital for patients undergoing anesthesia
American Society of Anesthesiologists (ASA)Patients receiving neuromuscular blocking medications as part of their anesthetic regimen should be carefully monitored to ensure the best care and outcomes, according to recent—and independently developed—guidelines from the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology and Intensive Care (ESAIC). Today, the organizations published a joint letter in Anesthesiology, ASA’s peer-reviewed medical journal, encouraging widespread implementation of the recommendations in the guidelines.